Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

BCA3 Inhibitors

BCA3 inhibitors encompass a diverse array of chemicals meticulously designed to target interactions involving the BCA3 protein within cellular pathways. These inhibitors operate by modulating well-established pathways governing critical cellular processes such as cell growth, inflammation, apoptosis, and proliferation. Their mechanisms of action vary widely, ranging from inhibiting kinase activity, as observed with Wortmannin's impact on PI3K, to suppressing pathway activation. By selectively targeting these pathways, BCA3 inhibitors hold the to disrupt any downstream effects that the protein might exert, providing a promising avenue for fine-tuning its cellular impact.

The remarkable versatility of BCA3 inhibitors highlights the crucial need to comprehend the precise cellular pathways and processes influenced by the BCA3 protein. This knowledge serves as a vital compass for the development or selection of inhibitors that can effectively and precisely target its functions. As researchers continue to unravel the intricate web of BCA3 interactions and their implications for cellular physiology, the applications of these inhibitors in medicine and biology become increasingly apparent. These inhibitors offer not only a means to probe the intricacies of BCA3's roles but also the promise of novel strategies for a wide range of conditions and diseases that involve the dysregulation of the cellular processes modulated by this protein.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a potent phosphoinositide 3-kinase (PI3K) inhibitor. If BCA3 interacts with the PI3K signaling pathway, Wortmannin can inhibit this pathway, potentially suppressing BCA3's downstream effects. This can affect cell growth, metabolism, and survival.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 inhibits PI3K, blocking its downstream effects. If BCA3 operates within the PI3K pathway, LY294002 can halt any associated cellular responses, impacting processes like cellular proliferation and metabolism.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a c-Jun N-terminal kinase (JNK) inhibitor. Should BCA3 be involved in JNK-mediated signaling, this inhibitor can disrupt pathway activation, affecting cellular responses to stress or inflammation.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 selectively inhibits p38 MAPK. If BCA3 is linked to the p38 MAPK pathway, SB203580 can modulate inflammatory responses and cellular apoptosis associated with this pathway.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is an ERK pathway inhibitor. If BCA3 has interactions within the ERK pathway, this inhibitor can affect cell differentiation and proliferation events mediated by this pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, a central cell growth regulator. If BCA3 is involved in mTOR signaling, Rapamycin can impact cell growth, proliferation, and survival.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$153.00
$356.00
15
(1)

ZM-447439 inhibits Aurora kinases. Should BCA3 be associated with cell cycle progression, this inhibitor can modulate cell division and growth.

IWP-2

686770-61-6sc-252928
sc-252928A
5 mg
25 mg
$96.00
$292.00
27
(1)

IWP-2 inhibits Wnt processing, impacting the Wnt signaling pathway. Should BCA3 be involved in Wnt-mediated cellular signaling, IWP-2 can affect cell fate determination and proliferation.

Alsterpaullone

237430-03-4sc-202453
sc-202453A
1 mg
5 mg
$68.00
$312.00
2
(1)

Alsterpaullone inhibits cyclin-dependent kinases. Should BCA3 be involved in cell cycle regulation, this compound can affect cell cycle progression and growth.